Cirrhosis With Septic Shock Clinical Trial
Official title:
Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension
300 consecutive patients with cirrhosis of any aetiology admitted with features of sepsis
and sepsis induced hypotension to the intensive care unit, the emergency department and the
step down units of Institute of Liver and Biliary Sciences, New Delhi, who fulfil the
inclusion criteria.
This study will be a single centre prospective randomized comparative trial. Patients will
be randomized into two groups. Group A will receive crystalloid, 0.9% sodium chloride
solution (total of 30ml/kg over 30 minutes) and Group B will receive colloid, 5% albumin
(250 ml over 15 minutes).
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01836224 -
Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care Unit
|
N/A | |
| Completed |
NCT02468063 -
To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock
|
N/A |